MedTrace Logo

Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction

NCT00901056 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-01-25

No results posted yet for this study

Summary

Low intensity shockwaves have been proven in animal studies to induce local growth of new blood vessels from existing ones.

The hypothesis of this study is that shockwave therapy could improve the symptoms of patients with erectile dysfunction resulted from a vascular origin and respond to PDE-5 inhibitors.

Conditions

Interventions

DEVICE

Extracorporeal Shockwave Therapy

Energy Density - 0.02 - 0.15 mJ/mm2

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER

  • Medispec

    lead INDUSTRY

Principal Investigators

  • Yoram Vardi, Professor · Rambam Health Care Campus

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901056 on ClinicalTrials.gov